SCM
INSY

Scopia Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Scopia Capital Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,131,221
Closed -$65.6M – 47
2016
Q4 		$65.6M Sell
7,131,221
-1,997,792
-22% -$22.6M 1.28% 24
2016
Q3 		$108M Buy
9,129,013
+141,700
+2% +$2.15M 2.26% 19
2016
Q2 		$116M Buy
8,987,313
+75,241
+0.8% +$1.1M 2.6% 18
2016
Q1 		$143M Buy
8,912,072
+3,087,987
+53% +$58.6M 2.91% 15
2015
Q4 		$167M Buy
5,824,085
+4,105,598
+239% +$114M 3.58% 9
2015
Q3 		$48.9M Buy
1,718,487
+846,573
+97% +$31.2M 1.2% 26
2015
Q2 		$31.3M Buy
+871,914
New +$27.2M 0.73% 27

Other funds holding INSY

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return